Neurological Biomarker Market Report

Europe Neurological Biomarker Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 14, 2019
  • PAGES：189
  • REPORT CODE：GMM320532
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Neurological Biomarker market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Neurological Biomarker Market Segmentations:

    By Player:

    • Acumen Pharmaceuticals

    • Proteome Sciences

    • QIAGEN

    • Athena Diagnostics

    • Cisbio Bioassays

    • Banyan Biomarkers

    • Alseres Pharmaceuticals

    • Psynova Neurotech

    • Thermo Fisher Scientific

    • Aepodia

    • AbaStar MDx

    • Abiant

    • Proteosys

    • Diagenic

    • Myriad RBM

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Biomarker Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Neurological Biomarker Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Neurological Biomarker Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Neurological Biomarker Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Neurological Biomarker Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Neurological Biomarker Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Neurological Biomarker Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Neurological Biomarker Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurological Biomarker by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Neurological Biomarker Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurological Biomarker by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurological Biomarker for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Neurological Biomarker for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Neurological Biomarker for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Neurological Biomarker Production Analysis by Top Regions

    • 5.2 Europe Neurological Biomarker Consumption Analysis by Top Regions

    • 5.3 Europe Neurological Biomarker Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.3 France Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Production, Import, Consumption and Export Analysis

    6 Product Circulation of Neurological Biomarker Market among Top Countries

    • 6.1 Top 5 Export Countries in Neurological Biomarker Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Neurological Biomarker Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Neurological Biomarker Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neurological Biomarker Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Neurological Biomarker Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Neurological Biomarker Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Neurological Biomarker Landscape Analysis

    • 7.1 Germany Neurological Biomarker Landscape Analysis by Major Types

    • 7.2 Germany Neurological Biomarker Landscape Analysis by Major End-Users

    8. UK Neurological Biomarker Landscape Analysis

    • 8.1 UK Neurological Biomarker Landscape Analysis by Major Types

    • 8.2 UK Neurological Biomarker Landscape Analysis by Major End-Users

    9. France Neurological Biomarker Landscape Analysis

    • 9.1 France Neurological Biomarker Landscape Analysis by Major Types

    • 9.2 France Neurological Biomarker Landscape Analysis by Major End-Users

    10. Italy Neurological Biomarker Landscape Analysis

    • 10.1 Italy Neurological Biomarker Landscape Analysis by Major Types

    • 10.2 Italy Neurological Biomarker Landscape Analysis by Major End-Users

    11. Spain Neurological Biomarker Landscape Analysis

    • 11.1 Spain Neurological Biomarker Landscape Analysis by Major Types

    • 11.2 Spain Neurological Biomarker Landscape Analysis by Major End-Users

    12. Poland Neurological Biomarker Landscape Analysis

    • 12.1 Poland Neurological Biomarker Landscape Analysis by Major Types

    • 12.2 Poland Neurological Biomarker Landscape Analysis by Major End-Users

    13. Russia Neurological Biomarker Landscape Analysis

    • 13.1 Russia Neurological Biomarker Landscape Analysis by Major Types

    • 13.2 Russia Neurological Biomarker Landscape Analysis by Major End-Users

    14. Switzerland Neurological Biomarker Landscape Analysis

    • 14.1 Switzerland Neurological Biomarker Landscape Analysis by Major Types

    • 14.2 Switzerland Neurological Biomarker Landscape Analysis by Major End-Users

    15. Turkey Neurological Biomarker Landscape Analysis

    • 15.1 Turkey Neurological Biomarker Landscape Analysis by Major Types

    • 15.2 Turkey Neurological Biomarker Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Landscape Analysis by Top Countries

      • 16.3.1 Denmark Neurological Biomarker Market Volume and Growth Rate

      • 16.3.2 Finland Neurological Biomarker Market Volume and Growth Rate

      • 16.3.3 Norway Neurological Biomarker Market Volume and Growth Rate

      • 16.3.4 Sweden Neurological Biomarker Market Volume and Growth Rate

      • 16.3.6 Iceland Neurological Biomarker Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Landscape Analysis by Top Countries

      • 17.3.1 Belgium Neurological Biomarker Market Volume and Growth Rate

      • 17.3.2 Netherlands Neurological Biomarker Market Volume and Growth Rate

      • 17.3.3 Luxembourg Neurological Biomarker Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Landscape Analysis by Top Countries

      • 18.3.1 Estonia Neurological Biomarker Market Volume and Growth Rate

      • 18.3.2 Latvia Neurological Biomarker Market Volume and Growth Rate

      • 18.3.3 Lithuania Neurological Biomarker Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Acumen Pharmaceuticals

      • 19.1.1 Acumen Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Proteome Sciences

      • 19.2.1 Proteome Sciences Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 QIAGEN

      • 19.3.1 QIAGEN Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Athena Diagnostics

      • 19.4.1 Athena Diagnostics Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Cisbio Bioassays

      • 19.5.1 Cisbio Bioassays Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Banyan Biomarkers

      • 19.6.1 Banyan Biomarkers Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Alseres Pharmaceuticals

      • 19.7.1 Alseres Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Psynova Neurotech

      • 19.8.1 Psynova Neurotech Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Thermo Fisher Scientific

      • 19.9.1 Thermo Fisher Scientific Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Aepodia

      • 19.10.1 Aepodia Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 AbaStar MDx

      • 19.11.1 AbaStar MDx Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Abiant

      • 19.12.1 Abiant Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Proteosys

      • 19.13.1 Proteosys Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Diagenic

      • 19.14.1 Diagenic Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Myriad RBM

      • 19.15.1 Myriad RBM Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 72 Figures and 129 Tables)

    • Figure Product Picture

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Neurological Biomarker Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure France Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Neurological Biomarker Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neurological Biomarker Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neurological Biomarker

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurological Biomarker by Different Types from 2014 to 2026

    • Table Consumption Share of Neurological Biomarker by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neurological Biomarker by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neurological Biomarker by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Neurological Biomarker Production by Major Regions

    • Table Europe Neurological Biomarker Production Share by Major Regions

    • Figure Europe Neurological Biomarker Production Share by Major Countries and Regions in 2014

    • Table Europe Neurological Biomarker Consumption by Major Regions

    • Table Europe Neurological Biomarker Consumption Share by Major Regions

    • Table Germany Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table UK Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table France Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Italy Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Spain Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Poland Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Russia Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Switzerland Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Turkey Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neurological Biomarker Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neurological Biomarker Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neurological Biomarker Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neurological Biomarker Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Germany Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Germany Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Germany Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table UK Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table UK Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table UK Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table UK Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table France Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table France Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table France Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table France Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Italy Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Italy Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Italy Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Italy Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Spain Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Spain Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Spain Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Spain Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Poland Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Poland Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Poland Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Poland Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Russia Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Russia Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Russia Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Russia Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Switzerland Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Switzerland Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Switzerland Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Turkey Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Turkey Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Turkey Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarker Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarker Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarker Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Neurological Biomarker Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Acumen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acumen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Acumen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Acumen Pharmaceuticals

    • Table Product and Service Introduction of Acumen Pharmaceuticals

    • Table Company Profile and Development Status of Proteome Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Proteome Sciences

    • Figure Sales and Growth Rate Analysis of Proteome Sciences

    • Figure Revenue and Market Share Analysis of Proteome Sciences

    • Table Product and Service Introduction of Proteome Sciences

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Athena Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Athena Diagnostics

    • Figure Sales and Growth Rate Analysis of Athena Diagnostics

    • Figure Revenue and Market Share Analysis of Athena Diagnostics

    • Table Product and Service Introduction of Athena Diagnostics

    • Table Company Profile and Development Status of Cisbio Bioassays

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cisbio Bioassays

    • Figure Sales and Growth Rate Analysis of Cisbio Bioassays

    • Figure Revenue and Market Share Analysis of Cisbio Bioassays

    • Table Product and Service Introduction of Cisbio Bioassays

    • Table Company Profile and Development Status of Banyan Biomarkers

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Banyan Biomarkers

    • Figure Sales and Growth Rate Analysis of Banyan Biomarkers

    • Figure Revenue and Market Share Analysis of Banyan Biomarkers

    • Table Product and Service Introduction of Banyan Biomarkers

    • Table Company Profile and Development Status of Alseres Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alseres Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alseres Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alseres Pharmaceuticals

    • Table Product and Service Introduction of Alseres Pharmaceuticals

    • Table Company Profile and Development Status of Psynova Neurotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Psynova Neurotech

    • Figure Sales and Growth Rate Analysis of Psynova Neurotech

    • Figure Revenue and Market Share Analysis of Psynova Neurotech

    • Table Product and Service Introduction of Psynova Neurotech

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Aepodia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aepodia

    • Figure Sales and Growth Rate Analysis of Aepodia

    • Figure Revenue and Market Share Analysis of Aepodia

    • Table Product and Service Introduction of Aepodia

    • Table Company Profile and Development Status of AbaStar MDx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbaStar MDx

    • Figure Sales and Growth Rate Analysis of AbaStar MDx

    • Figure Revenue and Market Share Analysis of AbaStar MDx

    • Table Product and Service Introduction of AbaStar MDx

    • Table Company Profile and Development Status of Abiant

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abiant

    • Figure Sales and Growth Rate Analysis of Abiant

    • Figure Revenue and Market Share Analysis of Abiant

    • Table Product and Service Introduction of Abiant

    • Table Company Profile and Development Status of Proteosys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Proteosys

    • Figure Sales and Growth Rate Analysis of Proteosys

    • Figure Revenue and Market Share Analysis of Proteosys

    • Table Product and Service Introduction of Proteosys

    • Table Company Profile and Development Status of Diagenic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Diagenic

    • Figure Sales and Growth Rate Analysis of Diagenic

    • Figure Revenue and Market Share Analysis of Diagenic

    • Table Product and Service Introduction of Diagenic

    • Table Company Profile and Development Status of Myriad RBM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad RBM

    • Figure Sales and Growth Rate Analysis of Myriad RBM

    • Figure Revenue and Market Share Analysis of Myriad RBM

    • Table Product and Service Introduction of Myriad RBM

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US